Loading clinical trials...
Loading clinical trials...
Multicentric Sensitivity Assessment of Antibody Diagnostic Tests Developed for Diagnosis of SARS-CoV2 Infection
Conditions
Locations
1
Italy
Istituto Ortopedico Galeazzi
Milan, Italy
Start Date
November 18, 2020
Primary Completion Date
August 1, 2021
Completion Date
November 1, 2021
Last Updated
December 24, 2020
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions